Fantasia $150 million high-yield notes reopening and concurrent tender offer
We advised the initial purchasers on the offering and the dealer managers on the tender offer for Fantasia’s senior notes
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares
Crowdstrike $400 million acquisition of Humio
We are advising Crowdstrike on the acquisition
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares
Charles River Laboratories $875 million acquisition of Cognate
We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
Cleveland-Cliffs $1 billion notes offering
We advised the initial purchasers on the high-yield debt offering
Corvus Pharmaceuticals $34 million stock offering
We advised the underwriters on the equity offering
JPMorgan Chase & Co. €1.5 billion notes offering
We advised JPMorgan Chase & Co. on the Euro notes offering
Technip Energies completes its spinoff from TechnipFMC
We advised Technip Energies on its spinoff
Tuatara Capital Acquisition $200 million IPO
We advised Tuatara, a SPAC, on its IPO and Nasdaq listing